Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Somatuline Depot (Lanreotide) Covered by Blue Cross Blue Shield in Illinois: Complete Prior Authorization and Appeal Guide

Answer Box: Your Fast Track to Somatuline Depot Coverage Blue Cross Blue Shield of Illinois requires prior authorization for Somatuline Depot (lanreotide) for commercial members. The fastest path: Have your prescriber submit documentation of your FDA-approved diagnosis (acromegaly, GEP-NETs, or carcinoid syndrome), any failed octreotide trials, and supporting labs via

How to Get Palynziq (pegvaliase-pqpz) Covered by Blue Cross Blue Shield in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Palynziq Covered in California Blue Cross Blue Shield (BCBS Association) requires prior authorization for Palynziq (pegvaliase-pqpz) in California, with coverage limited to PKU patients titrating to achieve blood phenylalanine ≤600 µmol/L. The fastest path: submit PA via provider portal with PKU diagnosis, current Phe levels, and

How to Get Ferriprox (deferiprone) Covered by Blue Cross Blue Shield in Georgia: Complete PA Guide with Appeal Scripts

Answer Box: Getting Ferriprox Covered by Blue Cross Blue Shield in Georgia Ferriprox (deferiprone) requires prior authorization from Blue Cross Blue Shield in Georgia for patients with transfusional iron overload. Your prescriber must submit documentation showing ferritin levels >1,000 ng/mL, baseline ANC ≥1,500/µL, and a

How to Get Tagrisso (Osimertinib) Covered by Blue Cross Blue Shield in New York: Appeals Guide and State Protections

Answer Box: Getting Tagrisso Covered by Blue Cross Blue Shield in New York Blue Cross Blue Shield requires prior authorization for Tagrisso (osimertinib) in New York. To get approved: (1) Confirm EGFR mutation testing shows qualifying mutations (exon 19 deletion, L858R, T790M), (2) Have your oncologist submit PA request with

How to Get Helixate (Antihemophilic Factor, rFVIII) Covered by Blue Cross Blue Shield of North Carolina: Complete PA Guide and Appeal Scripts

Answer Box: Getting Helixate Covered by BCBS North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Helixate (antihemophilic factor, rFVIII) as a specialty medication. Fastest path to approval: 1) Confirm your hematologist will prescribe through BCBSNC's Hemophilia Network pharmacy, 2) Submit PA with hemophilia

Myths vs. Facts: Getting Trikafta Covered by Blue Cross Blue Shield in Washington (2025 PA Guide)

Answer Box: Trikafta requires prior authorization from all Blue Cross Blue Shield plans in Washington, including Premera and Regence. Success depends on proper CFTR genotype documentation (F508del mutation), CF specialist attestation, and complete clinical records—not just a prescription. If denied, you have 180 days to appeal and can request

How to Get Evrysdi (Risdiplam) Covered by Horizon Blue Cross Blue Shield in New Jersey: PA Forms, Appeals Timeline & Success Strategies

Answer Box: Quick Path to Evrysdi Coverage Evrysdi (risdiplam) requires prior authorization from Horizon Blue Cross Blue Shield of New Jersey and must be dispensed through their specialty pharmacy network. To get approved: (1) Have your neurologist submit a PA form with genetic SMA confirmation, motor assessments, and prior therapy

How to Get Gattex (Teduglutide) Covered by Blue Cross Blue Shield in New York: Complete Appeals Guide with Forms and Timelines

Blue Cross Blue Shield in New York requires prior authorization for Gattex (teduglutide) with specific criteria: confirmed short bowel syndrome with parenteral nutrition dependence (≥3 days/week), documented enteral nutrition optimization failure, baseline colonoscopy within 6 months, and GI specialist involvement. If denied, file an internal appeal within 30 days,

How to Get Cosentyx (Secukinumab) Covered by Blue Cross Blue Shield in California: Prior Authorization Guide and Appeals Process

Quick Answer: Getting Cosentyx Covered by Blue Cross Blue Shield in California Cosentyx (secukinumab) is a preferred IL-17 inhibitor on Blue Shield of California formularies but requires prior authorization with step therapy through TNF inhibitors first. To get coverage: (1) Submit PA documentation including diagnosis codes, prior therapy failures, and

How to Get Qinlock (Ripretinib) Covered by Blue Cross Blue Shield in Florida: Complete Cost-Saving Guide and Appeals Strategy

Quick Answer: Getting Qinlock Covered by Florida Blue Cross Blue Shield Qinlock (ripretinib) requires prior authorization for Florida Blue plans, with placement on specialty tier (Tier 5-6) and quantity limits of 90 tablets per 30 days. Your oncologist must submit PA documentation showing progression after ≥3 prior kinase inhibitors (imatinib,